Local control in non-metastatic medulloblastoma.

about

Medulloblastoma in adults : A retrospective single institution analysis.

P2860

Q49938109-E261F88D-4BBE-4975-B723-922D458EB8FC

P2860

Local control in non-metastatic medulloblastoma.

Item

http://www.wikidata.org/entity/Q38225901

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Local control in non-metastatic medulloblastoma.

@en

type

Item

label

Local control in non-metastatic medulloblastoma.

@en

prefLabel

Local control in non-metastatic medulloblastoma.

@en

P1476

Local control in non-metastatic medulloblastoma.

@en

P2093

Christopher G Morris

http://www.w3.org/2001/XMLSchema#string

David W Pincus

http://www.w3.org/2001/XMLSchema#string

John A Fort

http://www.w3.org/2001/XMLSchema#string

Julie A Bradley

http://www.w3.org/2001/XMLSchema#string

Kaitlin M Christopherson

http://www.w3.org/2001/XMLSchema#string

Robert B Marcus

http://www.w3.org/2001/XMLSchema#string

Ronny L Rotondo

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular subgroups of medulloblastoma: the current consensus

Dissecting the genomic complexity underlying medulloblastoma

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

ADAM12 induces actin cytoskeleton and extracellular matrix reorganization during early adipocyte differentiation by regulating beta1 integrin function.

Long time to diagnosis of medulloblastoma in children is not associated with decreased survival or with worse neurological outcome

Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology.

Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961.

Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma

Pediatric medulloblastoma: toxicity of current treatment and potential role of protontherapy.

Management of and prognosis with medulloblastoma: therapy at a crossroads.

P304

1151-1157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/0284186X.2014.932434

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nancy P Mendenhall

Daniel Indelicato

P577

2014-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24991891

http://www.w3.org/2001/XMLSchema#string

P921

medulloblastoma

Local control in non-metastatic medulloblastoma.

about

P2860

P2860

Local control in non-metastatic medulloblastoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921